000 | 01692nam a2200229Ia 4500 | ||
---|---|---|---|
003 | NULRC | ||
005 | 20250520102854.0 | ||
008 | 250520s9999 xx 000 0 und d | ||
020 | _a812113462 | ||
040 | _cNULRC | ||
050 | _aRM 301.4 .G53 1991 | ||
100 |
_aGibaldi, Milo _eauthor |
||
245 | 0 |
_aBiopharmaceutics and clinical pharmacokinetics / _cMilo Gibaldi |
|
250 | _aFourth edition. | ||
260 |
_aPhiladelphia, Pennsylvania : _bLea & Febiger, _cc1991 |
||
300 |
_ax, 406 pages : _billustrations ; _c27 cm. |
||
504 | _aIncludes bibliographical references and index. | ||
505 | _aIntroduction to pharmacokinetics -- Compartmental and noncompartmental pharmacokinetics -- Gastrointestinal absorption--biologic considerations -- Gastrointestinal absorption--physicohemical considerations -- Gastrointestinal absorption--role of the dosage forms -- Nonoral medication -- Prolonged-release medication -- Bioavailability -- Drug concentration and clinical response -- Drug disposition--distribution -- Drug disposition--elimination -- Pharmacokinetic variability-- body weight, age, sex, and generic factors -- Pharmacokinetic variability--disease -- Pharmacokinetic variability--drug interactions -- Individualization and optimization of drug dosing regiments | ||
520 | _aThis updated introduction to the clinical applications of pharmacokinetics looks at gastrointestinal absorption, prolonged release medication, and drug disposition. The effects of disease, weight, age, sex and genetic factors on pharmacokinetic variability and drug response are detailed. Bioequivalence and regulatory considerations for generic drug. | ||
650 | _aBIOPHARMACEUTICS | ||
942 |
_2lcc _cBK |
||
999 |
_c17518 _d17518 |